SRF
You are completely correct in talking about Phase 2a.Importantly you placed priority on (a) because that is what it is and thats why and i quote from yesterdays announcement "with interim results potentially available in
early to mid 2013."
This clearly shows "intermin" results by mid 2013 hence your first stage of phase2 comments.
As clearly seen and as i spoke about a few weeks ago, results for Phase 2 are far off in the future and with a great deal of expense.Your 5 million is a bit optomistic i feel.This coupled with usual trial uncertainty is the key to investing in ANP IMO.
Any talk of "takeover of ATL1103 is so far off it isnt funny or relevent.Just bringing a bit of relevence and clarity here from what i mentioned a few weeks back coupled with the relevence of yesterdays announcement.
Hope this helps.
Cheers and a good post.
Rob
- Forums
- ASX - By Stock
- PER
- atl1103 development update
PER
percheron therapeutics limited
Add to My Watchlist
5.88%
!
0.8¢

atl1103 development update, page-59
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.8¢ |
Change
-0.001(5.88%) |
Mkt cap ! $8.699M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.8¢ | $2.021K | 252.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 7666804 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 2209483 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 7666804 | 0.008 |
6 | 2289427 | 0.007 |
4 | 1916833 | 0.006 |
2 | 1749997 | 0.005 |
1 | 1475000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 2209483 | 7 |
0.010 | 2904881 | 7 |
0.011 | 2582858 | 6 |
0.012 | 2658324 | 5 |
0.013 | 1500000 | 3 |
Last trade - 10.20am 15/07/2025 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
SPONSORED BY The Market Online